Next 10 |
home / stock / mdx:cc / mdx:cc news
MedX Health Corp. (“ MedX ” or the “ Company ”) (TSX-V: MDX) announces that it has completed the Initial Closing of the Private Placement originally announced on May 1, 2024, by issuance of 7,142,856 Units (as described below) to raise $500,000. A cash commissi...
MedX Health Corp. (“ MedX ” or the “ Company ”) (TSX-V: MDX) announced today that, subject to acceptance by the TSX-V, the ultimate Closing Date for the non-brokered Private Placement of up to $2 million, which was previously announced on May 1, 2024, will be e...
MedX Health Corp. (MDX:CA) is expected to report for Q1 2024
MedX Health Corp. (“ MedX ” or the “ Company ”) (TSX-V: MDX ) is pleased to announce that it is proposing to raise up to $2,000,000 by way of a Non-Brokered Private Placement of up to 28,571,428 Units at $0.07 per Unit (“Unit”). A Price Rese...
Health Partners, the UK’s largest non-hospital private healthcare services provider, with over two million patients across 550+ corporate, insurance and government clients, announced its intention to partner with MedX after successfully piloting MedX’s DermSecure ® Screenin...
Highlights: Dr. Cohen provides regular melanoma-related commentary to various media, including CTV, Global and CBC news outlets. MedX Health Corp. ("MedX" or the "Company") (TSX VENTURE: MDX) is pleased to announce that it has appointed Dr. Paul Cohen, a board-certified derm...
MedX Health Corp. (“ MedX ” or the “ Company ”) (TSX-V: MDX ) is pleased to announce that it is making an Application to the TSX-V for Acceptance of the proposed amendment to the terms of the currently outstanding Convertible Loan Notes (“ Series...
MedX Health Corp. (“ MedX ” or the “ Company ”) ( TSX-V: MDX ) is pleased to announce that, effective November 17, 2023, $2,965,000 of Secured Convertible Debentures were fully redeemed pursuant to exercise of the Conversion Rights by the Holders, resulting...
MedX Health Corp. (“ MedX ” or the “ Company ”) (TSX-V: MDX) announced today that, it has submitted for Final Acceptance from the TSXV and has closed the non-brokered Private Placement which was previously announced on August 30, 2023. The placement, to accredi...
MedX Health Corp. (“MedX” or the “Company”) (TSXV: MDX ), a global leader in teledermatology, is pleased to announce the appointment of veteran healthcare industry leader Jeffrey Morris as Vice President of Sales and Marketing. With over 20 years of experienc...
News, Short Squeeze, Breakout and More Instantly...
MedX Health Corp. (“ MedX ” or the “ Company ”) (TSX-V: MDX) announces that it has completed the Initial Closing of the Private Placement originally announced on May 1, 2024, by issuance of 7,142,856 Units (as described below) to raise $500,000. A cash commissi...
MedX Health Corp. (“ MedX ” or the “ Company ”) (TSX-V: MDX) announced today that, subject to acceptance by the TSX-V, the ultimate Closing Date for the non-brokered Private Placement of up to $2 million, which was previously announced on May 1, 2024, will be e...
MedX Health Corp. (MDX:CA) is expected to report for Q1 2024